Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.35 - $0.72 $70,268 - $144,551
-200,766 Reduced 13.25%
1,314,720 $486,000
Q4 2022

Feb 13, 2023

SELL
$0.32 - $8.27 $228,646 - $5.91 Million
-714,521 Reduced 32.04%
1,515,486 $591,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $7.2 $15,248 - $238,672
-33,149 Reduced 1.46%
2,230,007 $1.05 Million
Q2 2022

Aug 12, 2022

SELL
$0.58 - $1.13 $1.98 Million - $3.86 Million
-3,418,056 Reduced 60.16%
2,263,156 $1.32 Million
Q1 2022

May 12, 2022

SELL
$0.73 - $1.81 $53,548 - $132,770
-73,354 Reduced 1.27%
5,681,212 $5.74 Million
Q4 2021

Feb 10, 2022

BUY
$1.66 - $2.64 $1.22 Million - $1.95 Million
736,952 Added 14.69%
5,754,566 $9.55 Million
Q3 2021

Nov 09, 2021

BUY
$2.58 - $3.36 $205,904 - $268,154
79,808 Added 1.62%
5,017,614 $13.5 Million
Q2 2021

Aug 11, 2021

BUY
$2.7 - $3.81 $13.3 Million - $18.8 Million
4,937,806 New
4,937,806 $16.4 Million

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $22.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.